Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary Patou currently holds 24,896 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary Patou has been a net seller of XENE stock. They have purchased $35.9K and sold $11.9M worth of shares.
Gary Patou's most recent insider trade was on Jun 5, 2026, when they sold 1,322 shares at $53.14 per share.
Gary Patou serves as Executive at Xenon Pharmaceuticals Inc. (XENE). They have executed 85 insider transactions totaling $12.0M over their tenure at the company.
Gary Patou holds the position of Executive at Xenon Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Gary Patou has shown a selling trading pattern, with $35.9K in total purchases and $11.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gary Patou was on Jul 14, 2014, when they sold $2.4M worth of PCRX shares. This transaction involved 27,593 shares at $86.91 per share.
Gary Patou currently owns 24,896 shares of Xenon Pharmaceuticals Inc. (XENE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary Patou's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary Patou has 85 Form 4 filings on record as an insider at Xenon Pharmaceuticals Inc..
Set alerts for Gary Patou and 40,000+ other insiders.